Apparent Lack of


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 23 10 2019
accepted: 12 12 2019
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 5 11 2020
Statut: epublish

Résumé

Langerhans Cell Histiocytosis (LCH) is a neoplastic disorder of hematopoietic origin characterized by inflammatory lesions containing clonal histiocytes (LCH-cells) intermixed with various immune cells, including T cells. In 50-60% of LCH-patients, the somatic

Identifiants

pubmed: 31998317
doi: 10.3389/fimmu.2019.03045
pmc: PMC6967030
doi:

Substances chimiques

Antigens, Neoplasm 0
HLA-A Antigens 0
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3045

Informations de copyright

Copyright © 2020 Kemps, Zondag, Steenwijk, Andriessen, Borst, Vloemans, Roelen, Voortman, Verdijk, van Noesel, Cleven, Hawkins, Lang, de Ru, Janssen, Haasnoot, Franken, van Eijk, Solleveld-Westerink, van Wezel, Egeler, Beishuizen, van Laar, Abla, van den Bos, van Veelen and van Halteren.

Références

Int J Clin Exp Pathol. 2014 May 15;7(6):3166-73
pubmed: 25031736
Ann Hum Genet. 1955 Jun;19(4):251-3
pubmed: 14388528
Immunology. 2014 Jan;141(1):18-26
pubmed: 23927693
Front Immunol. 2018 Nov 13;9:2605
pubmed: 30555458
PLoS Med. 2007 Aug;4(8):e253
pubmed: 17696642
J Immunol. 2010 Apr 15;184(8):4557-67
pubmed: 20220088
Nat Rev Cancer. 2017 Apr;17(4):209-222
pubmed: 28233802
Blood. 1999 Dec 15;94(12):4195-201
pubmed: 10590064
Int J Clin Exp Pathol. 2012;5(6):503-11
pubmed: 22949932
J Exp Med. 2018 Jan 2;215(1):5-7
pubmed: 29269561
Immunogenetics. 2005 Apr;57(1-2):33-41
pubmed: 15744535
J Interferon Cytokine Res. 2015 Oct;35(10):831-9
pubmed: 26381039
Br J Dermatol. 1996 Jul;135(1):36-41
pubmed: 8776356
Blood. 2012 Dec 20;120(26):5199-208
pubmed: 23074278
Cancer Immunol Res. 2015 Jun;3(6):602-9
pubmed: 25795007
Science. 1995 Sep 1;269(5228):1281-4
pubmed: 7652577
Science. 2015 Dec 11;350(6266):1387-90
pubmed: 26516200
Blood. 2014 May 15;123(20):3152-5
pubmed: 24652991
Blood. 2016 Nov 24;128(21):2533-2537
pubmed: 27729324
J Exp Med. 2014 Apr 7;211(4):669-83
pubmed: 24638167
Ann Hum Genet. 1956 May;20(4):309-11
pubmed: 13314400
Blood. 2014 Nov 6;124(19):3007-15
pubmed: 25202140
Ann Oncol. 2018 Jan 1;29(1):271-279
pubmed: 29361136
J Exp Med. 2018 Jan 2;215(1):141-157
pubmed: 29203539
Cancer Discov. 2019 Oct;9(10):1406-1421
pubmed: 31345789
Oncotarget. 2015 Aug 14;6(23):19819-25
pubmed: 26110571
J Clin Oncol. 2016 Sep 1;34(25):3023-30
pubmed: 27382093
Eur J Cancer. 2000 Oct;36(16):2105-10
pubmed: 11044648
Pathology. 2017 Jun;49(4):397-404
pubmed: 28427753
Exp Mol Pathol. 2013 Feb;94(1):121-5
pubmed: 22750048
J Clin Invest. 2018 Apr 2;128(4):1563-1568
pubmed: 29360643
Cell Mol Life Sci. 2005 May;62(9):1025-37
pubmed: 15868101
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
J Clin Invest. 2016 Mar 1;126(3):854-8
pubmed: 26808500
J Immunol. 1999 Sep 15;163(6):3511-5
pubmed: 10477625
J Clin Immunol. 1986 Sep;6(5):355-62
pubmed: 3490486
Clin Immunol. 2018 Sep;194:19-25
pubmed: 29928999
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
Oncoimmunology. 2017 Mar 17;6(4):e1302631
pubmed: 28507809
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Blood. 2001 Mar 1;97(5):1241-8
pubmed: 11222366
J Immunol. 2016 Feb 15;196(4):1480-7
pubmed: 26783342
Hematol Oncol Clin North Am. 2015 Oct;29(5):839-51
pubmed: 26461146
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Cancer Res. 2006 Mar 15;66(6):3287-93
pubmed: 16540682
Curr Opin Immunol. 2016 Apr;39:44-51
pubmed: 26796069
N Engl J Med. 2016 Dec 8;375(23):2255-2262
pubmed: 27959684
J Vis Exp. 2019 Jan 29;(143):
pubmed: 30774138
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Sci Rep. 2018 Jan 8;8(1):67
pubmed: 29311575
Cancer Res. 2003 Sep 1;63(17):5209-12
pubmed: 14500346
BMC Genomics. 2017 Feb 14;18(1):161
pubmed: 28196473
Science. 2014 May 9;344(6184):641-5
pubmed: 24812403
Cell. 2007 Jun 15;129(6):1065-79
pubmed: 17574021
Pediatr Res. 2003 Jul;54(1):30-6
pubmed: 12700369
Nat Med. 2013 Jun;19(6):747-52
pubmed: 23644516
Cancer Res. 2004 Aug 1;64(15):5456-60
pubmed: 15289355
Ann Neurol. 2017 Feb;81(2):193-198
pubmed: 28026046
Clin Cancer Res. 2013 Aug 15;19(16):4295-6
pubmed: 23785048
BMC Genomics. 2014 Jan 24;15:63
pubmed: 24460756
Proteomics. 2018 Jun;18(12):e1800110
pubmed: 29791771
J Exp Med. 2003 May 19;197(10):1385-90
pubmed: 12743170
Med Pediatr Oncol. 2003 Dec;41(6):502-7
pubmed: 14595706
Blood. 2019 Apr 4;133(14):1607-1610
pubmed: 30696619
J Clin Oncol. 2013 Nov 10;31(32):e439-42
pubmed: 24043743
Mol Cancer Ther. 2014 Dec;13(12):2769-83
pubmed: 25385327
J Immunol Methods. 1997 Jul 14;205(2):201-9
pubmed: 9294602
Nat Immunol. 2011 Jan;12(1):45-53
pubmed: 21151101
J Immunother Cancer. 2019 Aug 14;7(1):217
pubmed: 31412943
Clin Cancer Res. 2015 Jul 15;21(14):3347-3355
pubmed: 25878334
Melanoma Res. 2016 Feb;26(1):1-11
pubmed: 26451873
Oncoimmunology. 2016 Jun 14;5(7):e1185582
pubmed: 27622040
Science. 2015 Apr 3;348(6230):69-74
pubmed: 25838375
Nature. 2016 Aug 4;536(7614):91-5
pubmed: 27350335
Cancer Res. 2008 Aug 1;68(15):6324-30
pubmed: 18676857
Arch Dermatol. 2010 Feb;146(2):149-56
pubmed: 20157025
Nature. 2015 Apr 30;520(7549):692-6
pubmed: 25901682
Genes Chromosomes Cancer. 2009 Mar;48(3):239-49
pubmed: 19051326
J Clin Invest. 2019 Feb 1;129(2):774-785
pubmed: 30640174
J Exp Med. 2005 Mar 7;201(5):687-93
pubmed: 15753204
Clin Cancer Res. 2014 Mar 1;20(5):1125-34
pubmed: 24323902
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Nat Med. 2015 Jan;21(1):81-5
pubmed: 25531942
Oncotarget. 2017 Jul 6;8(46):80443-80452
pubmed: 29113315
J Pathol. 1994 Oct;174(2):71-6
pubmed: 7965409
Neoplasia. 2014 Jan;16(1):31-42
pubmed: 24563618
Blood. 2012 Sep 20;120(12):e28-34
pubmed: 22859608
Curr Opin Genet Dev. 2007 Feb;17(1):31-9
pubmed: 17208430
Int J Cancer. 2009 Oct 1;125(7):1626-39
pubmed: 19569244
Lancet Oncol. 2017 Feb;18(2):e113-e125
pubmed: 28214412
Immunol Rev. 2010 Mar;234(1):213-32
pubmed: 20193021
Oncotarget. 2017 Dec 4;8(70):114935-114944
pubmed: 29383131
Brain. 2005 Apr;128(Pt 4):829-38
pubmed: 15705614
Cell. 2017 Jan 26;168(3):487-502.e15
pubmed: 28111070
Mol Cell Proteomics. 2013 Jul;12(7):1829-43
pubmed: 23481700
Cancer Res. 2004 Mar 1;64(5):1595-9
pubmed: 14996715
Cancer Immunol Res. 2016 Mar;4(3):204-14
pubmed: 26701267
Oncoimmunology. 2012 Jul 1;1(4):409-418
pubmed: 22754759
Science. 2018 Feb 2;359(6375):582-587
pubmed: 29217585
Semin Cell Dev Biol. 2019 Feb;86:62-76
pubmed: 29526544
Blood. 2010 Sep 16;116(11):1919-23
pubmed: 20519626

Auteurs

Paul G Kemps (PG)

Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.

Timo C Zondag (TC)

Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands.

Eline C Steenwijk (EC)

Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.

Quirine Andriessen (Q)

Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.

Jelske Borst (J)

Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.

Sandra Vloemans (S)

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.

Dave L Roelen (DL)

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.

Lenard M Voortman (LM)

Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.

Robert M Verdijk (RM)

Department of Pathology, Erasmus University Medical Center, Rotterdam, Netherlands.

Carel J M van Noesel (CJM)

Department of Pathology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Arjen H G Cleven (AHG)

Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

Cynthia Hawkins (C)

Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Veronica Lang (V)

Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Arnoud H de Ru (AH)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.

George M C Janssen (GMC)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.

Geert W Haasnoot (GW)

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.

Kees L M C Franken (KLMC)

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.

Ronald van Eijk (R)

Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

Nienke Solleveld-Westerink (N)

Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

Tom van Wezel (T)

Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

R Maarten Egeler (RM)

Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.
Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Auke Beishuizen (A)

Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.

Jan A M van Laar (JAM)

Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands.

Oussama Abla (O)

Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Cor van den Bos (C)

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Peter A van Veelen (PA)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.

Astrid G S van Halteren (AGS)

Immunology Laboratory Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH